Dialyte-AC

Dialyte-AC is a concentrated electrolyte solution that, after dilution according to dialysis machine specifications, is used to prepare the dialysate (bath) for hemodialysis treatment. It is indicated as part of the extracorporeal hemodialysis procedure to help correct fluid overload, electrolyte disturbances, and metabolic acidosis in patients with acute kidney injury or end-stage renal disease (ESRD) who require renal replacement therapy.

• Established use: As a buffering component of hemodialysate during maintenance or acute hemodialysis, to help normalize serum bicarbonate, sodium, potassium, calcium, and other electrolytes.
• Current practice note: Acetate-buffered dialysate formulations such as Dialyte-AC have largely been superseded by bicarbonate-based dialysate in modern hemodialysis practice due to better hemodynamic tolerability; acetate-containing solutions may still be used or referenced in specific clinical contexts or older equipment systems, at the discretion of the treating nephrology team.

Dialyte-AC is intended for use only as a component of the hemodialysis procedure performed in a hospital or dialysis center; it is not a self-administered outpatient medicine.

Acetate Formulation [Hemodialysis Solution] is typically supplied as a concentrated electrolyte solution intended for dilution with purified water for dialysis using the dialysis machine's proportioning system before use. A representative formulation contains sodium chloride, sodium acetate (as the acetate buffer source), potassium chloride, calcium chloride, and magnesium chloride, in water; some formulations may also contain dextrose. The exact electrolyte concentrations vary by product and are selected by the treating nephrology team based on the individual patient's electrolyte and acid-base status.

Dialyte-AC is an acetate-buffered concentrate used in the preparation of dialysate for hemodialysis. During dialysis, acetate diffuses into the patient's blood and is metabolized (chiefly in the liver and skeletal muscle) to bicarbonate, which helps correct the metabolic acidosis commonly seen in kidney failure while electrolytes equilibrate across the dialyzer membrane. Dialyte-AC is prepared, diluted, and administered strictly according to the dialysis machine manufacturer's instructions and the treating nephrology team's clinical protocol; it is not intended for direct patient self-administration.

Dialyte-AC belongs to the therapeutic class of hemodialysis solutions / renal dialysis concentrates, a category of electrolyte and buffer solutions used specifically in extracorporeal renal replacement therapy.

During hemodialysis, Acetate Formulation [Hemodialysis Solution] (diluted to form the dialysate) is circulated on one side of a semipermeable dialyzer membrane while the patient's blood flows on the other side. Diffusion and ultrafiltration move excess fluid, urea, and other waste products from blood into the dialysate, while electrolytes (sodium, potassium, calcium, magnesium) equilibrate toward the dialysate concentrations. The acetate component crosses into the blood and is metabolized to bicarbonate, chiefly by the liver and skeletal muscle, correcting metabolic acidosis. Because this bicarbonate generation is indirect and metabolism-dependent, acetate-based dialysate can produce more pronounced intradialytic hemodynamic effects (for example, vasodilation and hypotension) than direct bicarbonate-based dialysate, particularly in hemodynamically unstable or critically ill patients.

Dialyte-AC is administered only as part of the hemodialysis procedure, performed in a hospital or dialysis center by trained dialysis/nephrology healthcare personnel using approved dialysis equipment. The concentrate is diluted with the appropriate volume of purified water via the dialysis machine's automated proportioning system to form the final dialysate, which contacts the patient's blood indirectly across the dialyzer membrane during the extracorporeal circuit. Dialyte-AC must never be self-administered by patients.

Dialyte-AC can affect, or be affected by, medicines that alter electrolyte levels or cardiac conduction, because dialysis produces relatively rapid shifts in serum potassium, calcium, and pH:

• Digoxin and other cardiac glycosides: Rapid shifts in potassium and calcium during dialysis with Dialyte-AC can increase the risk of digoxin-related cardiac arrhythmias; digoxin levels and cardiac status should be monitored closely around dialysis sessions.
• Antihypertensive and vasodilator medicines: Because acetate-based dialysate is more commonly associated with intradialytic hypotension than bicarbonate-based dialysate, concurrent antihypertensives may increase the risk of symptomatic hypotension during dialysis; timing of doses relative to dialysis sessions should be individualized by the treating physician.
• Calcium-containing medicines or vitamin D analogs: May have additive effects with the calcium content of the dialysate; calcium levels should be monitored.

Side effects associated with Dialyte-AC are generally related to the hemodialysis procedure and the acetate buffer itself:

• Intradialytic hypotension (more frequently reported with acetate-based dialysate than bicarbonate-based dialysate)
• Nausea, vomiting, and headache during or after dialysis
• Muscle cramps
• Fatigue or lightheadedness related to fluid/electrolyte shifts
• Rarely, cardiac arrhythmia related to rapid electrolyte shifts

Patients should report any unusual symptoms during dialysis to their dialysis care team immediately.

Data on the use of Dialyte-AC specifically in pregnancy and lactation are limited. Hemodialysis itself is used when clinically necessary in pregnant patients with kidney failure, but dialysate composition, including use of Dialyte-AC, should be individualized by the treating nephrology and obstetric team, weighing the benefits of dialysis against potential risks. Dialyte-AC should be used in pregnant or breastfeeding patients only if clearly needed and if the potential benefit justifies the potential risk; a physician should always be consulted.

Dialyte-AC is intended solely for use as a component of hemodialysis performed in a hospital or dedicated dialysis center; it must be prepared, diluted, and used strictly according to the dialysis machine manufacturer's instructions and the treating clinical protocol.

• Hemodynamic monitoring: Intradialytic hypotension has historically been reported more frequently with acetate-based dialysate compared with bicarbonate-based formulations, particularly in hemodynamically unstable, elderly, or critically ill patients; the choice of dialysate buffer for a given patient is a clinical decision made by the treating nephrology team.
• Electrolyte and acid-base monitoring: Serum electrolytes, acid-base status, and fluid balance must be monitored regularly before, during, and after dialysis with Dialyte-AC.
• Hepatic impairment: Because acetate is metabolized mainly in the liver and muscle, patients with significant hepatic dysfunction may metabolize acetate less efficiently and should be monitored closely for acetate intolerance.
• Not for self-administration: This is a specialized, hospital/dialysis-center product; it is not a general outpatient or self-administered medication.

"Overdose" in the conventional sense does not apply to Dialyte-AC, since it is administered only under direct professional supervision using calibrated dialysis equipment. However, equipment malfunction, incorrect dilution, or protocol deviation could theoretically lead to excessive delivery of acetate or electrolytes, which may present as severe hypotension, arrhythmia, or acid-base disturbance. Any suspected error during dialysis should be treated as a medical emergency — the dialysis session should be stopped and the patient evaluated and treated immediately by the on-site medical team, with escalation to emergency services if needed.

Store Dialyte-AC at room temperature (below 30°C), away from light and moisture, and protect containers from freezing and contamination prior to use. Use only if the container and solution are clear and free of particulate matter or leaks. Keep out of reach of children and unauthorized personnel; this product is for use in a hospital/dialysis-center setting only.

Renal impairment: By definition, patients receiving Dialyte-AC have significant kidney failure requiring hemodialysis; dialysate composition is individualized accordingly.

Hepatic impairment: See Precautions and Warnings — acetate metabolism may be reduced; closer monitoring recommended.

Elderly: Older patients and those with cardiovascular instability may be more susceptible to intradialytic hypotension with acetate-based dialysate; careful hemodynamic monitoring is advised.

Pediatric patients: See Pediatric Use.

Pregnancy/lactation: See Pregnancy and Lactation.

The duration of exposure to Dialyte-AC corresponds to the duration of each hemodialysis session, typically about 3 to 4 hours, and the overall course of hemodialysis therapy (which may be short-term for acute kidney injury or long-term/chronic for end-stage renal disease) is determined by the treating nephrologist based on the patient's renal recovery or ongoing need for renal replacement therapy.

Dialyte-AC is supplied as a concentrate that must be diluted (reconstituted) with the appropriate volume of purified water for dialysis using the dialysis machine's automated proportioning system, according to the specific dilution ratio specified by the product labeling and the dialysis machine manufacturer, to produce the final dialysate used during treatment. Reconstitution must be performed only by trained dialysis personnel using validated equipment; manual or incorrect dilution can result in a dangerously incorrect dialysate composition.

Hemodialysis solutions; Renal dialysis concentrates; Electrolyte and acid-base balancing solutions

The acetate contained in Acetate Formulation [Hemodialysis Solution] diffuses from the dialysate into the patient's blood across the dialyzer membrane and is metabolized, mainly in the liver and skeletal muscle, into bicarbonate. This generated bicarbonate helps correct the metabolic acidosis typically present in kidney failure. Simultaneously, diffusive and convective transport across the dialyzer membrane removes excess fluid, urea, and other uremic toxins, and equilibrates serum electrolytes (sodium, potassium, calcium, magnesium) toward the concentrations present in the diluted Acetate Formulation [Hemodialysis Solution] dialysate.

Hemodialysis using dialysate prepared from Dialyte-AC may be used in pediatric patients with acute or chronic kidney failure who require renal replacement therapy; however, this must be performed only in a specialized pediatric dialysis unit under the direct supervision of a pediatric nephrologist, with dialysate composition, blood flow rate, and session duration individually adjusted for the child's size, weight, and clinical status. Safety and efficacy of specific dialysate formulations have not been established outside such specialist supervision, and pediatric patients may be more susceptible to hemodynamic instability during dialysis; close monitoring is required.